- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.29 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x 1VZ: 4-(pyrrolidin-1-yl)-1-{4-[2-(pyrrolidin-1-yl)ethyl]phenyl}piperidine(Non-covalent)
- 2 x SO4: SULFATE ION(Non-functional Binders)
SO4.2: 4 residues within 4Å:- Chain A: H.281, D.283, G.284, W.285
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:G.284, A:W.285
- Salt bridges: A:H.281
SO4.16: 4 residues within 4Å:- Chain B: H.281, D.283, G.284, W.285
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:G.284, B:W.285
- Salt bridges: B:H.281
- 24 x UNX: UNKNOWN ATOM OR ION(Non-functional Binders)
UNX.3: 1 residues within 4Å:- Chain A: V.303
Ligand excluded by PLIPUNX.4: 1 residues within 4Å:- Chain A: C.77
Ligand excluded by PLIPUNX.5: 4 residues within 4Å:- Chain A: C.6, S.9, Y.10, E.13
Ligand excluded by PLIPUNX.6: 5 residues within 4Å:- Chain A: H.27, S.29, Y.65, D.85, W.305
Ligand excluded by PLIPUNX.7: 3 residues within 4Å:- Chain A: K.68, W.81, M.263
Ligand excluded by PLIPUNX.8: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPUNX.9: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPUNX.10: 2 residues within 4Å:- Chain A: P.128, K.129
Ligand excluded by PLIPUNX.11: 2 residues within 4Å:- Chain A: I.89, E.133
Ligand excluded by PLIPUNX.12: 2 residues within 4Å:- Chain A: H.177, N.180
Ligand excluded by PLIPUNX.13: 2 residues within 4Å:- Chain A: D.258, R.260
Ligand excluded by PLIPUNX.14: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPUNX.17: 1 residues within 4Å:- Chain B: V.303
Ligand excluded by PLIPUNX.18: 1 residues within 4Å:- Chain B: C.77
Ligand excluded by PLIPUNX.19: 4 residues within 4Å:- Chain B: C.6, S.9, Y.10, E.13
Ligand excluded by PLIPUNX.20: 5 residues within 4Å:- Chain B: H.27, S.29, Y.65, D.85, W.305
Ligand excluded by PLIPUNX.21: 3 residues within 4Å:- Chain B: K.68, W.81, M.263
Ligand excluded by PLIPUNX.22: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPUNX.23: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPUNX.24: 2 residues within 4Å:- Chain B: P.128, K.129
Ligand excluded by PLIPUNX.25: 2 residues within 4Å:- Chain B: I.89, E.133
Ligand excluded by PLIPUNX.26: 2 residues within 4Å:- Chain B: H.177, N.180
Ligand excluded by PLIPUNX.27: 2 residues within 4Å:- Chain B: D.258, R.260
Ligand excluded by PLIPUNX.28: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Camerino, M.A. et al., The structure-activity relationships of L3MBTL3 inhibitors: flexibility of the dimer interface. Medchemcomm (2013)
- Release Date
- 2013-07-10
- Peptides
- Lethal(3)malignant brain tumor-like protein 3: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.29 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x 1VZ: 4-(pyrrolidin-1-yl)-1-{4-[2-(pyrrolidin-1-yl)ethyl]phenyl}piperidine(Non-covalent)
- 2 x SO4: SULFATE ION(Non-functional Binders)
- 24 x UNX: UNKNOWN ATOM OR ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Camerino, M.A. et al., The structure-activity relationships of L3MBTL3 inhibitors: flexibility of the dimer interface. Medchemcomm (2013)
- Release Date
- 2013-07-10
- Peptides
- Lethal(3)malignant brain tumor-like protein 3: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A